|
|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 395 active entries
Virdings Allé 2
SE-754 50 Uppsala
Sweden Phone: +46-18-55 20 40
Fax: +46-18-55 20 41
Description:
Cavidi, founded in 1984 by virologists from Uppsala University, is revolutionizing ultra-sensitive immunoassay signal amplification. Its flagship brand Exazym®, powered by BOLD (Binding Oligo Ladder Detection) technology, boosts immunoassay sensitivity up to 100x with minimal background noise. Originally developed for COVID-19 testing, Exazym® is now applied to a wide range of low-abundance biomarkers. Cavidi brings these innovations to market through research kits, services, licensing, and partnerships for in-vitro diagnostic applications.
Selected Categories:
Last update of this entry: September 24, 2025
|